Switch theme
Sign up to access all valuation multiples
Outset Medical Inc is a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis. The Company generates revenue from the sales of Tablo consoles and related consumables, including Tablo cartridges and accessories.
2003
354
LTM Revenue $118M
LTM EBITDA -$56.0M
$280M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Outset Medical has a last 12-month revenue (LTM) of $118M and a last 12-month EBITDA of -$56.0M.
In the most recent fiscal year, Outset Medical achieved revenue of $114M and an EBITDA of -$97.9M.
Outset Medical expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Outset Medical valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $118M | XXX | $114M | XXX | XXX | XXX |
| Gross Profit | $43.8M | XXX | $38.6M | XXX | XXX | XXX |
| Gross Margin | 37% | XXX | 34% | XXX | XXX | XXX |
| EBITDA | -$56.0M | XXX | -$97.9M | XXX | XXX | XXX |
| EBITDA Margin | -47% | XXX | -86% | XXX | XXX | XXX |
| EBIT | -$67.5M | XXX | -$113M | XXX | XXX | XXX |
| EBIT Margin | -57% | XXX | -100% | XXX | XXX | XXX |
| Net Profit | -$99.5M | XXX | -$128M | XXX | XXX | XXX |
| Net Margin | -84% | XXX | -113% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | $73.4M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of July 2, 2025, Outset Medical's stock price is $21.
Outset Medical has current market cap of $367M, and EV of $280M.
See Outset Medical trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $280M | $367M | XXX | XXX | XXX | XXX | $-15.98 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of July 2, 2025, Outset Medical has market cap of $367M and EV of $280M.
Outset Medical's trades at 2.5x EV/Revenue multiple, and -2.9x EV/EBITDA.
Equity research analysts estimate Outset Medical's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Outset Medical has a P/E ratio of -3.7x.
See valuation multiples for Outset Medical and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $367M | XXX | $367M | XXX | XXX | XXX |
| EV (current) | $280M | XXX | $280M | XXX | XXX | XXX |
| EV/Revenue | 2.4x | XXX | 2.5x | XXX | XXX | XXX |
| EV/EBITDA | -5.0x | XXX | -2.9x | XXX | XXX | XXX |
| EV/EBIT | -4.2x | XXX | -2.5x | XXX | XXX | XXX |
| EV/Gross Profit | 6.4x | XXX | n/a | XXX | XXX | XXX |
| P/E | -3.7x | XXX | -2.9x | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | -2.4x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialOutset Medical's last 12 month revenue growth is 10%
Outset Medical's revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $0.4M for the same period.
Outset Medical's rule of 40 is -108% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Outset Medical's rule of X is -23% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Outset Medical and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 10% | XXX | 10% | XXX | XXX | XXX |
| EBITDA Margin | -47% | XXX | -86% | XXX | XXX | XXX |
| EBITDA Growth | -30% | XXX | n/a | XXX | XXX | XXX |
| Rule of 40 | -108% | XXX | -76% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | -23% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.3M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.4M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 62% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | 34% | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 134% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Philips | XXX | XXX | XXX | XXX | XXX | XXX |
| Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
| InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
| Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Outset Medical acquired XXX companies to date.
Last acquisition by Outset Medical was XXXXXXXX, XXXXX XXXXX XXXXXX . Outset Medical acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Outset Medical founded? | Outset Medical was founded in 2003. |
| Where is Outset Medical headquartered? | Outset Medical is headquartered in United States of America. |
| How many employees does Outset Medical have? | As of today, Outset Medical has 354 employees. |
| Who is the CEO of Outset Medical? | Outset Medical's CEO is Ms. Leslie L. Trigg. |
| Is Outset Medical publicy listed? | Yes, Outset Medical is a public company listed on NAS. |
| What is the stock symbol of Outset Medical? | Outset Medical trades under OM ticker. |
| When did Outset Medical go public? | Outset Medical went public in 2020. |
| Who are competitors of Outset Medical? | Similar companies to Outset Medical include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
| What is the current market cap of Outset Medical? | Outset Medical's current market cap is $367M |
| What is the current revenue of Outset Medical? | Outset Medical's last 12 months revenue is $118M. |
| What is the current revenue growth of Outset Medical? | Outset Medical revenue growth (NTM/LTM) is 10%. |
| What is the current EV/Revenue multiple of Outset Medical? | Current revenue multiple of Outset Medical is 2.4x. |
| Is Outset Medical profitable? | Yes, Outset Medical is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Outset Medical? | Outset Medical's last 12 months EBITDA is -$56.0M. |
| What is Outset Medical's EBITDA margin? | Outset Medical's last 12 months EBITDA margin is -47%. |
| What is the current EV/EBITDA multiple of Outset Medical? | Current EBITDA multiple of Outset Medical is -5.0x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
